The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

“I remember we had one day where Matthew and I were not going to be in scenes for about three hours. And so he said, ‘Hey, do you want to go? Do you want to go play basketball at my hous ...

The project comes from work being driven by Dr. Matthew Memoli, the NIH’s principal deputy director, and Dr. Jeffery Taubenberger, acting director of NIAID. Memoli, who gained attention in 2021 ...

POWER is at the forefront of the global power market, providing in-depth news and insight on the end-to-end electricity system and the ongoing energy transition. We strive to be the “go-to ...

The project comes from work being driven by Dr. Matthew Memoli, the NIH’s principal deputy director, and Dr. Jeffery Taubenberger, acting director of NIAID. Memoli, who gained attention in 2021 for ...

The vaccine underwent testing for safety results earlier this year in a small study led by NIH researchers Dr. Matthew Memoli and Dr. Jeffery Taubenberger. The research was what scientists call a ...

The Trump administration has announced two key vaccine maneuvers in an effort to increase safety and reduce the number of injections given to Americans. The Department of Health and Human Services ...

whole-virus platform and is championed by Matthew Memoli, M.D., the newly tapped principal deputy director for the NIH, and Jeffery Taubenberger, M.D., Ph.D., who became acting director of the ...